Survival from Ovarian Cancer in England and Wales

publication Evidence: moderate

Author Information

Author(s): Kitchener H C

Primary Institution: University of Manchester

Ovarian cancer survival has improved due to better access to treatment and chemotherapy.

The overall improvement in 1-year survival is likely due to increased access to platinum-based chemotherapy.
Women who relapse more than 12 months after initial treatment may remain sensitive to platinum-based therapies.
The rise in 5-year survival reflects better access to optimal treatment and efforts to re-treat recurrent disease.

Ovarian cancer is hard to detect early, but treatments have gotten better, helping more women survive longer.

There is little evidence for the effectiveness of ovarian cancer screening methods currently being researched.

Access the complete publication on the publisher's website